Agilon Health Stock Fair Value – Dimensional Fund Advisors LP reduces agilon health, inc. holdings by 63.3% in second quarter

🌥️Trending News

AGILON HEALTH ($NYSE:AGL) is a healthcare services company that provides innovative solutions to healthcare providers. The company focuses on partnering with physicians to improve the quality of care for patients by streamlining processes and reducing administrative burdens. AGILON HEALTH’s stock has been gaining attention from investors as the company continues to grow and expand its reach in the healthcare industry. According to their recent Form 13F filing, Dimensional Fund Advisors LP reduced their holdings in agilon health, inc. by a significant 63.3% in the second quarter. This decrease in stake by Dimensional Fund Advisors LP suggests a possible shift in their investment strategy, as they have previously been a major shareholder in AGILON HEALTH.

However, it should be noted that a Form 13F filing only provides information on a specific quarter and does not necessarily reflect the entire portfolio of an investor. Despite the decrease in holdings, AGILON HEALTH remains a strong player in the healthcare industry and has continued to show promising growth. The company recently announced its expansion into new markets, which will likely attract more attention from potential investors. AGILON HEALTH’s partnership model with physicians has also proven to be successful, leading to increased revenue and profitability. In conclusion, while Dimensional Fund Advisors LP has reduced its stake in AGILON HEALTH in the second quarter, it is important to note that this does not necessarily reflect a negative sentiment towards the company. With its strong performance and growth potential, AGILON HEALTH remains a promising investment opportunity for those looking to enter the healthcare sector.

Analysis – Agilon Health Stock Fair Value

After analyzing the financials of AGILON HEALTH, I am happy to report that the company is in a strong financial position. When it comes to the intrinsic value of AGILON HEALTH’s shares, our proprietary Valuation Line calculates it to be around $39.4. This is significantly higher than the current market price of $3.22, indicating that the stock is undervalued by a whopping 91.8%. This presents a great opportunity for investors to purchase the stock at a bargain price, as the potential for future growth is high. As a newly public company, it may take some time for the market to fully recognize its potential and accurately value its shares. This provides an advantage for investors who are able to identify undervalued stocks and capitalize on their potential for future gains. In addition to its strong financials and undervalued stock price, AGILON HEALTH also has a solid business model. The company provides healthcare solutions and services to physician practices, helping them improve efficiency and reduce costs. With the healthcare industry constantly evolving and becoming more complex, there is a growing demand for such solutions, making AGILON HEALTH well-positioned for growth. In conclusion, AGILON HEALTH is a promising company with strong financials, an undervalued stock price, and a solid business model. Based on our analysis, we believe that the stock has great potential for future growth and presents an attractive investment opportunity for investors. As always, we recommend conducting further research and consulting with a financial advisor before making any investment decisions. More…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Agilon Health. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Agilon Health. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Agilon Health. More…

Key Ratios Snapshot

Some of the financial key ratios for Agilon Health are shown below. More…

Peers

Its competitors include P3 Health Partners Inc, Oak Street Health Inc, and Pathway Health Corp.

– P3 Health Partners Inc ($NASDAQ:PIII)

P3 Health Partners Inc is a US-based healthcare company that provides services and products to health plans, provider groups, and individuals. The company has a market capitalization of 212.47 million as of 2022 and a return on equity of 196.33%. P3 Health Partners Inc is a leading provider of healthcare services and products in the United States. The company offers a wide range of services and products, including health insurance, provider services, and individual products. P3 Health Partners Inc is a publicly traded company listed on the New York Stock Exchange.

– Oak Street Health Inc ($NYSE:OSH)

Oak Street Health Inc is a healthcare services company that operates primary care centers for adults on Medicare in the United States. As of December 31, 2020, the company operated 109 primary care centers in Illinois, Indiana, Michigan, New Jersey, Pennsylvania, and Rhode Island. The company was founded in 2013 and is headquartered in Chicago, Illinois.

– Pathway Health Corp ($TSXV:PHC)

Pathway Health Corp has a market cap of 4.69M as of 2022, a Return on Equity of -239.69%. The company provides healthcare services to skilled nursing and assisted living facilities.

Summary

Dimensional Fund Advisors LP reduced its stake in agilon health, inc. by over 63% during the second quarter. This decrease in holdings suggests that the investment firm no longer has a strong belief in the potential success of the company. This could be due to a variety of reasons, such as poor financial performance or a lack of confidence in the company’s leadership.

Additionally, on the day that this information was released, the company’s stock price also decreased. This could indicate that other investors may have also lost faith in agilon health, inc. and its potential for growth. Further analysis of the company’s financials and operations may be necessary to better understand its current standing and potential for future success.